TriangleFOR PATIENTS · SOURCE READING
Treatment of Untreated Acute Lymphoblastic Leukemia
Source: Acute Lymphoblastic Leukemia Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Treatment of ALL during the remission induction phase includes:
Source links and citations
combination chemotherapy
Source links and citations
targeted therapy with imatinib, in certain patients, some of whom will also have combination chemotherapy
Source links and citations
supportive care including antibiotics and red blood cell and platelet transfusions
Source links and citations
central nervous system (CNS) prophylaxis including chemotherapy (intrathecal and/or systemic) with or without radiation therapy to the brain
Source links and citations
Learn more about these treatments in the Treatment Option Overview.
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice